Mark Kaye - 03 Mar 2025 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP & CFO
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol
ELV
Transactions as of
03 Mar 2025
Net transactions value
-$106,785
Form type
4
Filing time
05 Mar 2025, 16:44:22 UTC
Previous filing
26 Feb 2025
Next filing
25 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Tax liability $106,785 -270 -1.3% $395.50 19,961 03 Mar 2025 Direct F1
transaction ELV Common Stock Award $0 +3,604 +18% $0.000000 23,565 03 Mar 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award $0 +13,713 $0.000000 13,713 03 Mar 2025 Common Stock 13,713 $395.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2 Represents restricted share units. Restrictions lapse as follows:1,201 shares each on 3/3/2026 and 3/3/2027, and 1,202 shares on 3/3/2028.
F3 Balance includes 17.59 shares acquired on December 20, 2024 through a dividend reinvestment plan.
F4 The option represents a right to purchase a total of 13,713 shares, and is exercisable in three annual installments of 4,571 shares each, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.